What is the market capitalization of Biofrontera Inc.?

Biofrontera Inc. (BFRI) has a market capitalization of approximately 12,617,696 USD.

Where can I buy BFRI in Canada?

BFRI can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

BFRI

Biofrontera Inc.

Biofrontera Inc. (BFRI) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 13 million USD (micro-cap).

Details

Price0.99 USD

Market cap12.62 M USD

Payout ratio0.00%

ROE-339.04%

Debt / Equity127.25%

SectorHealthcare

Websitebiofrontera-us.com

Updated 2h ago

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.